{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T20:54:04Z","timestamp":1768683244497,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1986,1,1]],"date-time":"1986-01-01T00:00:00Z","timestamp":504921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1986]]},"DOI":"10.1007\/bf00615952","type":"journal-article","created":{"date-parts":[[2004,11,26]],"date-time":"2004-11-26T11:32:37Z","timestamp":1101468757000},"page":"639-643","source":"Crossref","is-referenced-by-count":7,"title":["Isosorbide-5-mononitrate in the treatment of acute left ventricular failure following acute myocardial infarction"],"prefix":"10.1007","volume":"29","author":[{"given":"M. D.","family":"Gammage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. G.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. A.","family":"Littler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00618777","volume":"20","author":"U Abshagen","year":"1981","unstructured":"Abshagen U, Betzien G, Endele R, Kaufmann B (1981) Pharmacokinetics of intravenous and oral isosorbide-5-mononitrate. Eur J Clin Pharmacol 20: 269?275","journal-title":"Eur J Clin Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9149(79)90049-3","volume":"43","author":"TL Biddle","year":"1979","unstructured":"Biddle TL, Yu PN (1979) Effect of furosemide on haemodynamics and lung water in acute pulmonary edema secondary to myocardial infarction. Am J Cardiol 43: 86?90","journal-title":"Am J Cardiol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2165\/00003495-197509010-00002","volume":"9","author":"RN Brogden","year":"1975","unstructured":"Brogden RN, Speight TM, Avery GS (1975) Bumetanide: A preliminary report of its pharmacological properties and therapeutic efficacy in oedema. Drugs 9: 4?18","journal-title":"Drugs"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.1967.03120230076009","volume":"200","author":"M Davidov","year":"1967","unstructured":"Davidov M, Kakaviatos N, Finnerty FA (1967) Intravenous administration of furosemide in heart failure. J Am Med Assoc 200: 824?829","journal-title":"J Am Med Assoc"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/jps.2600630728","volume":"63","author":"WH Down","year":"1974","unstructured":"Down WH, Chaseaud LF, Grundy RK (1974) Biotransformation of isosorbide dinitrate in humans. J Pharm Sci 63: 1147?1149","journal-title":"J Pharm Sci"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0002-9149(71)90436-X","volume":"27","author":"W Ganz","year":"1971","unstructured":"Ganz W, Donoso R, Marcus HS, Forrester JS, Swan HJC (1971) A new technique for measurement of cardiac output by thermodilution in man. Am J Cardiol 27: 392?396","journal-title":"Am J Cardiol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/01.CIR.48.3.581","volume":"48","author":"J Kiely","year":"1973","unstructured":"Kiely J, Kelly DT, Taylor DR, Pitt B (1973) The role of furosemide in the treatment of left ventricular dysfunction associated with acute myocardial infarction. Circulation 48: 581?587","journal-title":"Circulation"},{"issue":"14a","key":"CR8","first-page":"521","volume":"32","author":"W Kosters","year":"1981","unstructured":"Kosters W, Klotschoff P, Abshagen U (1981) Pharmacokinetics of isosorbide-5-mononitrate in patients with advanced renal failure. Med Welt 32 (14a): 521?523","journal-title":"Med Welt"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/hrt.31.6.711","volume":"31","author":"S Lal","year":"1969","unstructured":"Lal S, Murtagh JG, Pollock AM, Fletcher E, Binnion PF (1969) Acute haemodynamic effects of frusemide in patients with normal and raised left atrial pressures. Br Heart J 31: 711?717","journal-title":"Br Heart J"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/hrt.36.1.44","volume":"36","author":"H Mond","year":"1974","unstructured":"Mond H, Hunt D, Sloman G (1974) Haemodynamic effects of frusemide in patients suspected of having acute myocardial infarction. Br Heart J 36: 44?53","journal-title":"Br Heart J"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0140-6736(83)92025-1","volume":"1","author":"GIC Nelson","year":"1983","unstructured":"Nelson GIC, Silke B, Ahuja RC, Hussain M, Taylor SH (1983) Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart failure following myocardial infarction. Lancet 1: 730?733","journal-title":"Lancet"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0006-2952(73)90255-4","volume":"22","author":"MT Rosseel","year":"1973","unstructured":"Rosseel MT, Bogaert MG (1973) Isosorbide, isomannide and isodide dinitrate: urinary excretion in the rat. Biochem Pharmacol 22: 67?72","journal-title":"Biochem Pharmacol"},{"key":"CR13","first-page":"296","volume":"176","author":"SA Sissenwine","year":"1971","unstructured":"Sissenwine SA, Ruelius HW (1971) Plasma concentrations and urinary excretion of isosorbide dinitrate and its metabolites in the dog. J Pharmacol Exp Ther 176: 296?301","journal-title":"J Pharmacol Exp Ther"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00563005","volume":"18","author":"S Sporl-Radun","year":"1980","unstructured":"Sporl-Radun S, Betzien G, Kaufmann B, Liede V, Abshagen U (1980) Effects and pharmacokinetics of isosorbide dinitrate in normal man. Eur J Clin Pharmacol 18: 237?244","journal-title":"Eur J Clin Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/bdd.2510010310","volume":"1","author":"T Taylor","year":"1980","unstructured":"Taylor T, Chasseaud LF, Doyle E (1980) Pharmacokinetics of isosorbide dinitrate after intravenous infusion in human subjects. Biopharm Drug Dispos 1: 149?156","journal-title":"Biopharm Drug Dispos"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/bdd.2510020306","volume":"2","author":"T Taylor","year":"1981","unstructured":"Taylor T, Chasseaud LF, Major R, Doyle E, Darragh A (1981) Isosorbide-5-mononitrate pharmacokinetics in humans. Biopharm Drug Dispos 2: 255?263","journal-title":"Biopharm Drug Dispos"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00615952.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00615952\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00615952","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T23:43:33Z","timestamp":1554421413000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00615952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1986]]}},"alternative-id":["BF00615952"],"URL":"https:\/\/doi.org\/10.1007\/bf00615952","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986]]}}}